{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:52:42Z","timestamp":1794293562360,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10633-019-09743-1","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T07:03:20Z","timestamp":1578035000000},"page":"279-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Electroretinographic abnormalities associated with pregabalin: a case report"],"prefix":"10.1007","volume":"140","author":[{"given":"Wakana","family":"Ninomiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5389-6507","authenticated-orcid":false,"given":"Kei","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1535-0279","authenticated-orcid":false,"given":"Takaaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Okude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7787-8194","authenticated-orcid":false,"given":"Satoshi","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"Masuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"9743_CR1","first-page":"828","volume":"2","author":"I Selak","year":"2001","unstructured":"Selak I (2001) Pregabalin (Pfizer). Curr Opin Investig Drugs 2:828\u2013834","journal-title":"Curr Opin Investig Drugs"},{"key":"9743_CR2","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/01.wnl.0000055433.55136.55","volume":"60","author":"RH Dworkin","year":"2003","unstructured":"Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60:1274\u20131283. https:\/\/doi.org\/10.1212\/01.wnl.0000055433.55136.55","journal-title":"Neurology"},{"key":"9743_CR3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1212\/01.wnl.0000068024.20285.65","volume":"60","author":"JA French","year":"2003","unstructured":"French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA (2003) Dose\u2013response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60:1631\u20131637. https:\/\/doi.org\/10.1212\/01.wnl.0000068024.20285.65","journal-title":"Neurology"},{"key":"9743_CR4","first-page":"1086","volume":"295","author":"DJ Dooley","year":"2000","unstructured":"Dooley DJ, Donovan CM, Pugsley TA (2000) Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 295:1086\u20131093","journal-title":"J Pharmacol Exp Ther"},{"key":"9743_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0304-3959(03)00173-8","volume":"105","author":"JC Fehrenbacher","year":"2003","unstructured":"Fehrenbacher JC, Taylor CP, Vasko MR (2003) Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 105:133\u2013141","journal-title":"Pain"},{"key":"9743_CR6","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.0409066103","volume":"103","author":"MJ Field","year":"2006","unstructured":"Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, Bramwell S, Corradini L, England S, Winks J, Kinloch RA, Hendrich J, Dolphin AC, Webb T, Williams D (2006) Identification of the alpha 2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 103:17537\u201317542. https:\/\/doi.org\/10.1073\/pnas.0409066103","journal-title":"Proc Natl Acad Sci USA"},{"key":"9743_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","volume":"73","author":"CP Taylor","year":"2007","unstructured":"Taylor CP, Angelotti T, Fauman E (2007) Pharmacology and mechanism of action of pregabalin: the calcium channel alpha 2-delta (alpha 2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73:137\u2013150. https:\/\/doi.org\/10.1016\/j.eplepsyres.2006.09.008","journal-title":"Epilepsy Res"},{"key":"9743_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.1654596","volume":"253","author":"WA Catterall","year":"1991","unstructured":"Catterall WA (1991) Functional subunit structure of voltage-gated calcium channels. Science 253:1499\u20131500. https:\/\/doi.org\/10.1126\/science.1654596","journal-title":"Science"},{"key":"9743_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0143-4160(98)90055-0","volume":"24","author":"WA Catterall","year":"1998","unstructured":"Catterall WA (1998) Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium 24:307\u2013323","journal-title":"Cell Calcium"},{"key":"9743_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","volume":"45","author":"S Arroyo","year":"2004","unstructured":"Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S, Group P-IS (2004) Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose\u2013response study in adults with partial seizures. Epilepsia 45:20\u201327. https:\/\/doi.org\/10.1111\/j.0013-9580.2004.31203.x","journal-title":"Epilepsia"},{"key":"9743_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1528-1167.2008.01954.x","volume":"50","author":"BI Lee","year":"2009","unstructured":"Lee BI, Yi S, Hong SB, Kim MK, Lee SA, Lee SK, Shin DJ, Kim JM, Song HK, Heo K, Lowe W, Leon T (2009) Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial. Epilepsia 50:464\u2013474. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01954.x","journal-title":"Epilepsia"},{"key":"9743_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/15569527.2016.1141420","volume":"36","author":"S Akta\u015f","year":"2017","unstructured":"Akta\u015f S, Tetiko\u011flu M, \u0130nan S, Akta\u015f H, \u00d6zcura F (2017) Unilateral hemorrhagic macular infarction associated with marijuana, alcohol and antiepileptic drug intake. Cutan Ocul Toxicol 36:88\u201395. https:\/\/doi.org\/10.3109\/15569527.2016.1141420","journal-title":"Cutan Ocul Toxicol"},{"key":"9743_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4274\/tjo.70923","volume":"48","author":"B Tany\u0131ld\u0131z","year":"2018","unstructured":"Tany\u0131ld\u0131z B, Kandemir B, Mangan MS, Tany\u0131ld\u0131z A, G\u00f6kta\u015f E, \u015eim\u015fek \u015e (2018) Bilateral serous macular detachment after attempted suicide with pregabalin. Turk J Ophthalmol 48:254\u2013257. https:\/\/doi.org\/10.4274\/tjo.70923","journal-title":"Turk J Ophthalmol"},{"key":"9743_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130:1\u201312. https:\/\/doi.org\/10.1007\/s10633-014-9473-7","journal-title":"Doc Ophthalmol"},{"key":"9743_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-017-9621-y","volume":"136","author":"AG Robson","year":"2018","unstructured":"Robson AG, Nilsson J, Li S, Jalali S, Fulton AB, Tormene AP, Holder GE, Brodie SE (2018) ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol 136:1\u201326. https:\/\/doi.org\/10.1007\/s10633-017-9621-y","journal-title":"Doc Ophthalmol"},{"key":"9743_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/13816810.2014.991931","volume":"37","author":"S Katagiri","year":"2016","unstructured":"Katagiri S, Hayashi T, Kondo M, Tsukitome H, Yoshitake K, Akahori M, Ikeo K, Tsuneoka H, Iwata T (2016) RPE65 mutations in two Japanese families with Leber congenital amaurosis. Ophthalmic Genet 37:161\u2013169. https:\/\/doi.org\/10.3109\/13816810.2014.991931","journal-title":"Ophthalmic Genet"},{"key":"9743_CR17","first-page":"286","volume":"24","author":"S Katagiri","year":"2018","unstructured":"Katagiri S, Hosono K, Hayashi T, Kurata K, Mizobuchi K, Matsuura T, Yoshitake K, Iwata T, Nakano T, Hotta Y (2018) Early onset flecked retinal dystrophy associated with new compound heterozygous RPE65 variants. Mol Vis 24:286\u2013296","journal-title":"Mol Vis"},{"key":"9743_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000301211","volume":"123","author":"G Schubert","year":"1952","unstructured":"Schubert G, Bornschein H (1952) Analysis of the human electroretinogram. Ophthalmologica 123:396\u2013413. https:\/\/doi.org\/10.1159\/000301211","journal-title":"Ophthalmologica"},{"key":"9743_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archopht.1986.01050190071042","volume":"104","author":"Y Miyake","year":"1986","unstructured":"Miyake Y, Yagasaki K, Horiguchi M, Kawase Y, Kanda T (1986) Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol 104:1013\u20131020. https:\/\/doi.org\/10.1001\/archopht.1986.01050190071042","journal-title":"Arch Ophthalmol"},{"key":"9743_CR20","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/hmg\/ddi336","volume":"14","author":"F Mansergh","year":"2005","unstructured":"Mansergh F, Orton NC, Vessey JP, Lalonde MR, Stell WK, Tremblay F, Barnes S, Rancourt DE, Bech-Hansen NT (2005) Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synaptic transmission and cellular organization in mouse retina. Hum Mol Genet 14:3035\u20133046. https:\/\/doi.org\/10.1093\/hmg\/ddi336","journal-title":"Hum Mol Genet"},{"key":"9743_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S095252380623102X","volume":"23","author":"B Chang","year":"2006","unstructured":"Chang B, Heckenlively JR, Bayley PR, Brecha NC, Davisson MT, Hawes NL, Hirano AA, Hurd RE, Ikeda A, Johnson BA, McCall MA, Morgans CW, Nusinowitz S, Peachey NS, Rice DS, Vessey KA, Gregg RG (2006) The nob2 mouse, a null mutation in Cacna1f: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci 23:11\u201324. https:\/\/doi.org\/10.1017\/S095252380623102X","journal-title":"Vis Neurosci"},{"key":"9743_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.preteyeres.2014.09.001","volume":"45","author":"C Zeitz","year":"2015","unstructured":"Zeitz C, Robson AG, Audo I (2015) Congenital stationary night blindness: an analysis and update of genotype\u2013phenotype correlations and pathogenic mechanisms. Prog Retin Eye Res 45:58\u2013110. https:\/\/doi.org\/10.1016\/j.preteyeres.2014.09.001","journal-title":"Prog Retin Eye Res"},{"key":"9743_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/81619","volume":"26","author":"NT Bech-Hansen","year":"2000","unstructured":"Bech-Hansen NT, Naylor MJ, Maybaum TA, Sparkes RL, Koop B, Birch DG, Bergen AA, Prinsen CF, Polomeno RC, Gal A, Drack AV, Musarella MA, Jacobson SG, Young RS, Weleber RG (2000) Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 26:319\u2013323. https:\/\/doi.org\/10.1038\/81619","journal-title":"Nat Genet"},{"key":"9743_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/s0002-9394(14)72791-6","volume":"119","author":"TS Chang","year":"1995","unstructured":"Chang TS, Aylward W, Clarkson JG, Gass JD (1995) Asymmetric canthaxanthin retinopathy. Am J Ophthalmol 119:801\u2013802. https:\/\/doi.org\/10.1016\/s0002-9394(14)72791-6","journal-title":"Am J Ophthalmol"},{"key":"9743_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-4939-0597-3_10","volume-title":"Hydroxychloroquine and chloroquine retinopathy","author":"DJ Browning","year":"2014","unstructured":"Browning DJ (2014) Clinical examples in managing patients taking 4-aminoquinolines. In: Browning DJ (ed) Hydroxychloroquine and chloroquine retinopathy. Springer, New York, pp 247\u2013286"},{"key":"9743_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000750","author":"HG Mack","year":"2018","unstructured":"Mack HG, Fuzzard DRW, Symons RCA, Heriot WJ (2018) Asymmetric hydroxychloroquine macular toxicity with aphakic fellow eye. Retin Cases Brief Rep. https:\/\/doi.org\/10.1097\/ICB.0000000000000750","journal-title":"Retin Cases Brief Rep"},{"key":"9743_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10633-007-9074-9","volume":"116","author":"G Goetgebuer","year":"2008","unstructured":"Goetgebuer G, Kestelyn-Stevens AM, De Laey JJ, Kestelyn P, Leroy BP (2008) Cancer-associated retinopathy (CAR) with electronegative ERG: a case report. Doc Ophthalmol 116:49\u201355. https:\/\/doi.org\/10.1007\/s10633-007-9074-9","journal-title":"Doc Ophthalmol"},{"key":"9743_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10633-014-9470-x","volume":"130","author":"S Ueno","year":"2015","unstructured":"Ueno S, Nakanishi A, Nishi K, Suzuki S, Terasaki H (2015) Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs. Doc Ophthalmol 130:71\u201376. https:\/\/doi.org\/10.1007\/s10633-014-9470-x","journal-title":"Doc Ophthalmol"},{"key":"9743_CR29","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/IAE.0000000000002329","volume":"39","author":"S Ueno","year":"2018","unstructured":"Ueno S, Inooka D, Nakanishi A, Okado S, Yasuda S, Kominami T, Sayo A, Morimoto T, Kondo M, Katagiri S, Hayashi T, Terasaki H (2019) Clinical course of paraneoplastic retinopathy with anti-TRPM1 autoantibody in Japanese cohort. Retina. 39:2410\u20132418","journal-title":"Retina"},{"key":"9743_CR30","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.bbamem.2012.11.019","volume":"1828","author":"AC Dolphin","year":"2013","unstructured":"Dolphin AC (2013) The alpha2delta subunits of voltage-gated calcium channels. Biochim Biophys Acta 1828:1541\u20131549. https:\/\/doi.org\/10.1016\/j.bbamem.2012.11.019","journal-title":"Biochim Biophys Acta"},{"key":"9743_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1023\/B:JOBB.0000008028.41056.58","volume":"35","author":"N Klugbauer","year":"2003","unstructured":"Klugbauer N, Marais E, Hofmann F (2003) Calcium channel alpha2delta subunits: differential expression, function, and drug binding. J Bioenerg Biomembr 35:639\u2013647","journal-title":"J Bioenerg Biomembr"},{"key":"9743_CR32","first-page":"2554","volume":"43","author":"S Yoshida","year":"2002","unstructured":"Yoshida S, Yashar BM, Hiriyanna S, Swaroop A (2002) Microarray analysis of gene expression in the aging human retina. Investig Ophthalmol Vis Sci 43:2554\u20132560","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"9743_CR33","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1523\/JNEUROSCI.19-02-00684.1999","volume":"19","author":"N Klugbauer","year":"1999","unstructured":"Klugbauer N, Lacinov\u00e1 L, Marais E, Hobom M, Hofmann F (1999) Molecular diversity of the calcium channel alpha2delta subunit. J Neurosci 19:684\u2013691","journal-title":"J Neurosci"},{"key":"9743_CR34","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1523\/JNEUROSCI.21-16-06095.2001","volume":"21","author":"J Barclay","year":"2001","unstructured":"Barclay J, Balaguero N, Mione M, Ackerman SL, Letts VA, Brodbeck J, Canti C, Meir A, Page KM, Kusumi K, Perez-Reyes E, Lander ES, Frankel WN, Gardiner RM, Dolphin AC, Rees M (2001) Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J Neurosci 21:6095\u20136104","journal-title":"J Neurosci"},{"key":"9743_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exer.2013.03.012","volume":"111","author":"J Huang","year":"2013","unstructured":"Huang J, Zhou L, Wang H, Luo J, Zeng L, Xiong K, Chen D (2013) Distribution of thrombospondins and their neuronal receptor \u03b12\u03b41 in the rat retina. Exp Eye Res 111:36\u201349. https:\/\/doi.org\/10.1016\/j.exer.2013.03.012","journal-title":"Exp Eye Res"},{"key":"9743_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF02703642","volume":"26","author":"TC Nag","year":"2001","unstructured":"Nag TC, Wadhwa S (2001) Differential expression of syntaxin-1 and synaptophysin in the developing and adult human retina. J Biosci 26:179\u2013191","journal-title":"J Biosci"},{"key":"9743_CR37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/947","volume":"19","author":"NT Bech-Hansen","year":"1998","unstructured":"Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA, Mets M, Musarella MA, Boycott KM (1998) Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet 19:264\u2013267. https:\/\/doi.org\/10.1038\/947","journal-title":"Nat Genet"},{"key":"9743_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/940","volume":"19","author":"TM Strom","year":"1998","unstructured":"Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BH, Wutz K, Gutwillinger N, R\u00fcther K, Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A, Meindl A (1998) An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 19:260\u2013263. https:\/\/doi.org\/10.1038\/940","journal-title":"Nat Genet"},{"key":"9743_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1086\/508067","volume":"79","author":"C Zeitz","year":"2006","unstructured":"Zeitz C, Kloeckener-Gruissem B, Forster U, Kohl S, Magyar I, Wissinger B, M\u00e1ty\u00e1s G, Borruat FX, Schorderet DF, Zrenner E, Munier FL, Berger W (2006) Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet 79:657\u2013667. https:\/\/doi.org\/10.1086\/508067","journal-title":"Am J Hum Genet"},{"key":"9743_CR40","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1086\/508944","volume":"79","author":"KA Wycisk","year":"2006","unstructured":"Wycisk KA, Zeitz C, Feil S, Wittmer M, Forster U, Neidhardt J, Wissinger B, Zrenner E, Wilke R, Kohl S, Berger W (2006) Mutation in the auxiliary calcium-channel subunit CACNA2D4 causes autosomal recessive cone dystrophy. Am J Hum Genet 79:973\u2013977. https:\/\/doi.org\/10.1086\/508944","journal-title":"Am J Hum Genet"},{"key":"9743_CR41","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1167\/iovs.06-0271","volume":"47","author":"KA Wycisk","year":"2006","unstructured":"Wycisk KA, Budde B, Feil S, Skosyrski S, Buzzi F, Neidhardt J, Glaus E, Nurnberg P, Ruether K, Berger W (2006) Structural and functional abnormalities of retinal ribbon synapses due to Cacna2d4 mutation. Investig Ophthalmol Vis Sci 47:3523\u20133530. https:\/\/doi.org\/10.1167\/iovs.06-0271","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"9743_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1124\/mol.62.3.485","volume":"62","author":"N Qin","year":"2002","unstructured":"Qin N, Yagel S, Momplaisir ML, Codd EE, D\u2019Andrea MR (2002) Molecular cloning and characterization of the human voltage-gated calcium channel alpha(2)delta-4 subunit. Mol Pharmacol 62:485\u2013496. https:\/\/doi.org\/10.1124\/mol.62.3.485","journal-title":"Mol Pharmacol"},{"key":"9743_CR43","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nn1320","volume":"7","author":"F Haeseleer","year":"2004","unstructured":"Haeseleer F, Imanishi Y, Maeda T, Possin DE, Maeda A, Lee A, Rieke F, Palczewski K (2004) Essential role of Ca2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat Neurosci 7:1079\u20131087. https:\/\/doi.org\/10.1038\/nn1320","journal-title":"Nat Neurosci"},{"key":"9743_CR44","first-page":"2414","volume":"42","author":"CW Morgans","year":"2001","unstructured":"Morgans CW (2001) Localization of the alpha(1F) calcium channel subunit in the rat retina. Investig Ophthalmol Vis Sci 42:2414\u20132418","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"668\u2013671","key":"9743_CR45","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1016\/j.ophtha.2015.09.045","volume":"123","author":"R Ba-Abbad","year":"2016","unstructured":"Ba-Abbad R, Arno G, Carss K, Stirrups K, Penkett CJ, Moore AT, Michaelides M, Raymond FL, Webster AR, Holder GE (2016) Mutations in CACNA2D4 cause distinctive retinal dysfunction in humans. Ophthalmology 123(668\u2013671):e662. https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.045","journal-title":"Ophthalmology"},{"key":"9743_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ejhg.2014.141","volume":"23","author":"S Vergult","year":"2015","unstructured":"Vergult S, Dheedene A, Meurs A, Faes F, Isidor B, Janssens S, Gautier A, Le Caignec C, Menten B (2015) Genomic aberrations of the CACNA2D1 gene in three patients with epilepsy and intellectual disability. Eur J Hum Genet 23:628\u2013632. https:\/\/doi.org\/10.1038\/ejhg.2014.141","journal-title":"Eur J Hum Genet"},{"key":"9743_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/jmedgenet-2012-101223","volume":"50","author":"S Edvardson","year":"2013","unstructured":"Edvardson S, Oz S, Abulhijaa FA, Taher FB, Shaag A, Zenvirt S, Dascal N, Elpeleg O (2013) Early infantile epileptic encephalopathy associated with a high voltage gated calcium channelopathy. J Med Genet 50:118\u2013123. https:\/\/doi.org\/10.1136\/jmedgenet-2012-101223","journal-title":"J Med Genet"},{"key":"9743_CR48","doi-asserted-by":"publisher","first-page":"e82154","DOI":"10.1371\/journal.pone.0082154","volume":"8","author":"T Pippucci","year":"2013","unstructured":"Pippucci T, Parmeggiani A, Palombo F, Maresca A, Angius A, Crisponi L, Cucca F, Liguori R, Valentino ML, Seri M, Carelli V (2013) A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy. PLoS ONE 8:e82154. https:\/\/doi.org\/10.1371\/journal.pone.0082154","journal-title":"PLoS ONE"},{"key":"9743_CR49","doi-asserted-by":"publisher","first-page":"6308283","DOI":"10.1155\/2018\/6308283","volume":"2018","author":"KM Butler","year":"2018","unstructured":"Butler KM, Holt PJ, Milla SS, da Silva C, Alexander JJ, Escayg A (2018) Epileptic encephalopathy and cerebellar atrophy resulting from compound heterozygous CACNA2D2 variants. Case Rep Genet 2018:6308283. https:\/\/doi.org\/10.1155\/2018\/6308283","journal-title":"Case Rep Genet"},{"key":"9743_CR50","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/acn3.50824","volume":"6","author":"J Punetha","year":"2019","unstructured":"Punetha J, Karaca E, Gezdirici A, Lamont RE, Pehlivan D, Marafi D, Appendino JP, Hunter JV, Akdemir ZC, Fatih JM, Jhangiani SN, Gibbs RA, Innes AM, Posey JE, Lupski JR (2019) Biallelic CACNA2D2 variants in epileptic encephalopathy and cerebellar atrophy. Ann Clin Transl Neurol 6:1395\u20131406. https:\/\/doi.org\/10.1002\/acn3.50824","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-019-09743-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-019-09743-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-019-09743-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:09:26Z","timestamp":1609546166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-019-09743-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9743"],"URL":"https:\/\/doi.org\/10.1007\/s10633-019-09743-1","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"7 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest regarding this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements of human rights"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}},{"value":"Informed consent was obtained from the patient included in this report.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}